share_log

HC Wainwright & Co. Maintains Buy on Celularity, Lowers Price Target to $2.5

HC Wainwright & Co. Maintains Buy on Celularity, Lowers Price Target to $2.5

HC Wainwright & Co.维持对Celularity的买入,将目标价下调至2.5美元
Benzinga Real-time News ·  2023/01/30 05:44

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Celularity (NASDAQ:CELU) with a Buy and lowers the price target from $15 to $2.5.

HC Wainwright&Co.分析师Swayampakula Ramakanth维持Celulality(纳斯达克代码:CELU)为买入,并将目标价从15美元下调至2.5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发